N
Nuvation Bio D
D
NUVB
4.79500
USD
-0.36
(-6.89%)
مغلق
حجم التداول
89,870
الربح لكل سهم
-0
العائد الربحي
-
P/E
-11
حجم السوق
1,669,628,451
العنوان: Nuvation Bio
القطاع: Healthcare
الصناعة: Biotechnology
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.